- Home
- KLTR vs STTK Comparison
KLTR vs STTK Comparison
Compare KLTR & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- STTK
- Stock Information
- Founded
- KLTR 2006
- STTK 2016
- Country
- KLTR United States
- STTK United States
- Employees
- KLTR N/A
- STTK N/A
- Industry
- KLTR EDP Services
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- KLTR Technology
- STTK Health Care
- Exchange
- KLTR Nasdaq
- STTK Nasdaq
- Market Cap
- KLTR 177.3M
- STTK 173.6M
- IPO Year
- KLTR 2021
- STTK 2020
- Fundamental
- Price
- KLTR $1.09
- STTK $3.50
- Analyst Decision
- KLTR Buy
- STTK Strong Buy
- Analyst Count
- KLTR 3
- STTK 3
- Target Price
- KLTR $2.67
- STTK $10.67
- AVG Volume (30 Days)
- KLTR 107.9K
- STTK 155.6K
- Earning Date
- KLTR 08-08-2024
- STTK 08-01-2024
- Dividend Yield
- KLTR N/A
- STTK N/A
- EPS Growth
- KLTR N/A
- STTK N/A
- EPS
- KLTR N/A
- STTK N/A
- Revenue
- KLTR $176,832,000.00
- STTK $4,123,999.00
- Revenue This Year
- KLTR $2.29
- STTK $164.45
- Revenue Next Year
- KLTR $2.32
- STTK N/A
- P/E Ratio
- KLTR N/A
- STTK N/A
- Revenue Growth
- KLTR 2.65
- STTK 380.09
- 52 Week Low
- KLTR $0.76
- STTK $1.33
- 52 Week High
- KLTR $2.03
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- KLTR 40.14
- STTK 47.31
- Support Level
- KLTR $1.18
- STTK $3.37
- Resistance Level
- KLTR $1.39
- STTK $3.69
- Average True Range (ATR)
- KLTR 0.08
- STTK 0.23
- MACD
- KLTR -0.02
- STTK 0.06
- Stochastic Oscillator
- KLTR 9.23
- STTK 51.92
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.